Visited 22 House and Senate offices (staff members) to update them on the approval timeline of our new drug.
MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AFFYMAX, INC.
2445 M Street, NW, Suite 373, Washington, DC, 20037, US
PAUL SMEDBERG